Furthermore, IL (including IL-2, IL-15, and IL-18)-induced NK cells inhibited the proliferation of MCF7 cells (NK cells on breast cancer cells) and increased the release of TNF-α, IFN-γ, PRF1, and GzmB [37]. Here, PRF1 is linked to breast carcinoma.